Helios Biotechnology JSC (HOSE:HSL)
Vietnam · Delayed Price · Currency is VND 7,820.00
+60.00 (0.77%)
At close: Oct 14, 2026
Helios Biotechnology JSC Revenue
Helios Biotechnology JSC had revenue of 394.64M VND in the quarter ending June 30, 2026, a decrease of -98.55%. This brings the company's revenue in the last twelve months to 10.39B, down -84.16% year-over-year. In the year 2025, Helios Biotechnology JSC had annual revenue of 45.94B, down -67.01%. That makes Helios Biotechnology JSC the 44,741st largest company in the world by revenue and 664th in Vietnam.
Revenue (ttm)
10.39B
Revenue Growth
-84.16%
P/S Ratio
29.02
Revenue / Employee
2.08B
Employees
5
Market Cap
301.60B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 45.94B | -93.31B | -67.01% |
| Dec 31, 2024 | 139.25B | -250.49B | -64.27% |
| Dec 31, 2023 | 389.73B | 167.85B | 75.65% |
| Dec 31, 2017 | 221.88B | 54.77B | 32.78% |
| Jan 1, 2017 | 167.11B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| VNSteel - Hochiminh City Metal | 7.97T |
| Pha Le Plastics Manufacturing and Technology JSC | 3.24T |
| Construction Joint Stock Company 47 | 1.63T |
| Vinalink Logistics JSC | 1.54T |
| YBM JSC | 975.11B |
| Ben Tre Pharmaceutical JSC | 873.41B |
| Japan Vietnam Medical Investment and Development JSC | 747.22B |
| Southern Seed | 268.75B |